Cell Reports Medicine (Oct 2021)

Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis

  • Selena Ferrian,
  • Candace C. Liu,
  • Erin F. McCaffrey,
  • Rashmi Kumar,
  • Theodore S. Nowicki,
  • David W. Dawson,
  • Alex Baranski,
  • John A. Glaspy,
  • Antoni Ribas,
  • Sean C. Bendall,
  • Michael Angelo

Journal volume & issue
Vol. 2, no. 10
p. 100419

Abstract

Read online

Summary: Immune checkpoint blockade using PD-1 inhibition is an effective approach for treating a wide variety of cancer subtypes. While lower gastrointestinal (GI) side effects are more common, upper gastrointestinal adverse events are rarely reported. Here, we present a case of nivolumab-associated autoimmune gastritis. To elucidate the immunology underlying this condition, we leverage multiplexed ion beam imaging by time-of-flight (MIBI-TOF) to identify the presence and proportion of infiltrating immune cells from a single section of biopsy specimen. Using MIBI-TOF, we analyze formalin-fixed, paraffin-embedded human gastric tissue with 28 labels simultaneously. Our analyses reveal a gastritis characterized by severe mucosal injury, interferon gamma (IFN-γ)-producing gastric epithelial cells, and mixed inflammation that includes CD8 and CD4 T cell infiltrates with reduced expression of granzyme B and FOXP3, respectively. Here, we provide a comprehensive multiplexed histopathological mapping of gastric tissue, which identifies IFN-γ-producing epithelial cells as possible contributors to the nivolumab-associated gastritis.

Keywords